Egypt’s Eva Pharma to export COVID-19 drug remdesivir to India
Photo source: Reuters
Spread the news

Egypt’s Eva Pharma on Monday signed an agreement to provide India with 300,000 doses of remdesivir, used in the treatment of COVID-19, the company said in a statement.

The agreement, which was signed at the Indian embassy in Cairo, is aimed at helping India combat a surge in infection on Monday.

Embassy of India, Cairo deeply appreciated that Eva Pharma has delivered its first batch of 40,000 vials of Remdesivir to India on 13 May2021, well ahead of schedule.

Subscribe to The Times Of Africa

Subscribe to our email newsletter for useful tips and valuable resources, sent out every Tuesday.


Leave a Reply

Your email address will not be published. Required fields are marked *